Replies to post #1449 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

GG et al: Thrombomodulin is a bona fide competitor in DIC/sepsis. The private company developing it is Artisan Pharma, which is based in Framingham, Massachusetts of all places and has a Japanese connection.

They just raised $39M in a Series A private placement:
http://www.artisanpharma.net/pressReleasepdf.pdf

p.s. This is the link to the abstract you posted last week:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&l...

Dew